Synthesis and ligand binding studies of 4'-iodobenzyl esters of tropanes and piperidines at the dopamine transporter

Journal of Medicinal Chemistry

Volumn 40, Issue 16, 1997, Pages 2474-2481

  Singh, Satendra ^a   Basmadjian, Garo P ^a   Avor, Kwasi S ^a   Pouw, Buddy ^a   Seale, Thomas W ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' IODOBENZOYL ESTER; 4' IODOCOCAINE; COCAINE; DOPAMINE TRANSPORTER; ECGONINE; PIPERIDINE DERIVATIVE; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; ESTERIFICATION; HYDROXYLATION; LIGAND BINDING; LOCOMOTION; MOUSE; NERVE STIMULATION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ESTERS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MODELS, CHEMICAL; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; TROPANES;

EID: 0030788357     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970121i     Document Type: Article

References (33)

1. Withers, N. W.; Pulvirenti, L.; Koob, G. F.; Gillin, J. C. Cocaine abuse and dependence J. Clin. Psychopharmacol. 1995, 15, 63-78.
2. Johnson, C. E.; Fischman, M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 1989, 41, 3-52.
3. Kuhar, M. J.; Ritz, M. C.; Boja, J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 1991, 14, 299-302.
4. Robinson, T.; Barridge, K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 1993, 18, 249-291.
5. Ritz, M. C.; Lamb, R. J.; Goldberg, R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237, 1219-1223.
6. Giros, B.; Jaber, M.; Jones, S. R.; Wightman, R. M.; Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379, 606-612.
7. Witkin, J. M. Pharmacotherapy of cocaine abuse: preclinical development. Neurosci. Behav. Rev. 1994, 18, 121-142.
8. Tutton, C. S.; Crayton, J. W. Current pharmacotherapies for cocaine abuse: a review. J. Addict. Dis. 1993, 12, 109-127.
9. Kotian, P.; Mascarella, S. W.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J.; Carroll, F. I. Synthesis, ligand binding, and quantitative structure-activity relationship study of 3β-(4′-substituted phenyl)-2β-heterocyclic tropanes: evidence for an electrostatic interaction at the 2β position. J. Med. Chem. 1996, 39, 2753-2763.
10. Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; KuharM. J. Synthesis, ligand binding, QSAR, and CoMFA study of 3β-(p-substituted phenyl)-tropane-20-carboxylic acid methyl esters. J. Med. Chem. 1991, 34, 2719-2725.
11. Meltzer, P. C.; Lian, A. Y.; Brownell, A.-L.; Elmaleh, D. R.; Madras B. K. Substituted 3β-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging. J. Med. Chem. 1993, 36, 855-862.
12. Carroll, F. I.; Kotian, P.; Dehghani, A.; Gray, J. L.; Kuzemko, M. A.; Parham, K. A.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar M. J. Cocaine and 3β-(4-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogs. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 1995, 38, 379-388.
13. Simoni, D.; Stoelwinder, J.; Kozikowski, A. P.; Johnson, K. M.; Bergman, J. S.; Ball, R. G. Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine antagonist. J. Med. Chem. 1993, 36, 3975-3977.
14. 3H]WIN 35,428. Synapse 1989, 4, 390-392.
15. 3H]-2-carbomethoxy-3-(4-fluorophenyl)tropane. Mol. Pharmacol. 1989, 36, 518-124.
16. 125I]RTI-55: a potent ligand for dopamine transporters. Eur. J. Pharmacol. 1991, 194, 133-134.
17. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane: high affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem. 1991, 34, 3144-3146.
18. Carroll, F. I.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 1992, 35, 969-981.
19. Tolliver, B. K.; Carney, J. M. Locomotor stimulant effects of cocaine and novel cocaine analogs in DBA/2J and C57BL/6J inbred mice. Pharmacol. Biochem. Behav. 1995, 50, 163-169.
20. Fleckenstein, A. E.; Kopajtic, T. A.; Boja, J. W.; Carroll, F. I.; Kuhar, M. J. Highly potent cocaine analogs cause long-lasting increases in locomotor activity. Eur. J. Pharmacol. 1996, 311, 109-114.
21. Seale, T. W.; Niekrasz, I.; Chang, F.; Singh, S.; Basmadjian, G. P. Selective behavioral alterations on addition of a 4′-phenyl group to cocaine. NeuroReport 1996, 7, 617-621.
22. 2- and OH-substituted cocaine differ behaviorally and neurochemically. NeuroReport, in press.
23. Yu, D.-W.; Galley, S. J.; Wolf, A. P.; Macgregor, R. R.; Dewey, S. L.; Fowler, J. S.; Schlyer, D. J. Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. J. Med. Chem. 1992, 35, 2178-2183.
24. Carey, J. G.; Millar, I. T. Formation and stability of aryldiazonium iodides and triiodides. Chem. Ind. (London) 1960, 97.
25. Meltzer, P. C.; Liang, A. Y.; Madras, B. K. The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem. 1994, 37, 2001-2010.
26. Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of Organic Compounds; Wiley: New York, 1994; pp 665-834.
27. Smith, R. M. Arylhydroxymetabolites of cocaine in the urine of cocaine users. J. Anal. Toxicol. 1984, 8, 35-37.
28. Tamagnan, G.; Gao, Y.; Bakthavachalam, V.; White, W. L.; Neumeyer, J. L. An efficient synthesis of m-hydroxycocaine and m-hydroxybenzoylecgonine, two metabolites of cocaine. Tetrahedron Lett. 1995, 36, 5861-5864.
29. 3H]-tropane to the dopamine uptake carrier. J. Neurochem. 1993, 61, 167-177.
30. Carroll, F. I.; Mascarella, S. W.; Kuzemko, M. A.; Gao, Y.; Abraham, P.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 30-(3′-substituted phenyl)-, 3β-(4′-substituted phenyl)-, and 3β-(3′,4′-disubstituted phenyl)tropane-2β-carboxylic acid methyl esters. J. Med. Chem. 1994, 37, 2865-2873.
31. Deutsch, H. M.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M. M. Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs. J. Med. Chem. 1996, 39, 1201-1209.
32. Basmadjian, G. P.; Seale, T. W.; Chang, F.; Zhang, Y.; Sastrodjojo, B.; Singh, S.; Avor, K. S.; Mills, S. L. A novel cocaine analog, 4′-iodococaine (4-IC), selectively blocks cocaine's action and binding at the dopamine transporter. ACS National Meeting, Anaheim, CA; Div. of Med. Chem. Poster No. 208, 1995.
33. Kitayama, S.; Shimada, S.; Xu, H.; Markham, L.; Donovan, D. M.; Uhl, G. R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7782-7785.